Ovarian cancer drug to be launched in UK at US price
ISLAMABAD: AbbVie said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the US.
US President Donald Trump has been demanding that drugmakers align domestic prices with the lowest levels…
